Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Verastem Oncology jumps 22% on FDA nod for Avmapki Fakzynja, the first approved KRAS-mutant LGSOC therapy, with strong early data in a pancreatic cancer study.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

A young tech professional from Delhi set social media abuzz after sharing his incredible journey: from starting out at Rs 5.5 ...

In the high-octane world of franchise cricket, logic and madness walk hand in hand — sometimes with a strategic time-out in ...

Edible Garden AG Incorporated ("Edible Garden" or the "Company") (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified ...

An EMR-based prompt significantly boosted molecular testing rates and detection of actionable mutations in early-stage, ...

Illumina Inc. today announced an expanded clinical oncology portfolio, unlocking the next new solutions to advance precision oncology and improve the standard of care. The company's broad range of ...

After Plattekill Supervisor Dean DePew welcomed everyone to this year’s Memorial Day ceremony at the town park, veterans ...

HAMILTON, Bermuda I May 27, 2025 I Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB:CYTOF), a company dedicated to developing and ...